These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Sarr MG; Hamilton SR; Marrone GC; Cameron JL Am J Surg; 1985 Jan; 149(1):187-93. PubMed ID: 3966636 [TBL] [Abstract][Full Text] [Related]
43. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297 [TBL] [Abstract][Full Text] [Related]
44. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux. Hamilton SR; Hutcheon DF; Ravich WJ; Cameron JL; Paulson M Gastroenterology; 1984 Feb; 86(2):356-60. PubMed ID: 6690363 [TBL] [Abstract][Full Text] [Related]
45. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M Digestion; 2000; 61(1):6-13. PubMed ID: 10671769 [TBL] [Abstract][Full Text] [Related]
46. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL. DE Carli DM; Araujo AF; Fagundes RB Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045 [TBL] [Abstract][Full Text] [Related]
48. Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics. Camus M; Khungar V; Jensen DM; Ohning GV; Kovacs TO; Jutabha R; Ghassemi KA; Machicado GA; Dulai GS Dig Dis Sci; 2016 Sep; 61(9):2732-40. PubMed ID: 27286877 [TBL] [Abstract][Full Text] [Related]
49. Gastric surgery does not increase the risk of developing Barrett's esophagus. Parrilla P; Liron R; Martinez de Haro LF; Ortiz A; Molina J; De Andrés B Am J Gastroenterol; 1997 Jun; 92(6):960-3. PubMed ID: 9177510 [TBL] [Abstract][Full Text] [Related]
50. Characteristics of intestinal metaplasia in the gastric cardia. El-Serag HB; Sonnenberg A; Jamal MM; Kunkel D; Crooks L; Feddersen RM Am J Gastroenterol; 1999 Mar; 94(3):622-7. PubMed ID: 10086641 [TBL] [Abstract][Full Text] [Related]
51. White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. Acosta A; Streett S; Kroh MD; Cheskin LJ; Saunders KH; Kurian M; Schofield M; Barlow SE; Aronne L Clin Gastroenterol Hepatol; 2017 May; 15(5):631-649.e10. PubMed ID: 28242319 [TBL] [Abstract][Full Text] [Related]
52. [The prevalence of esophageal disorders in the subjects examined for health screening]. Yoo SS; Lee WH; Ha J; Choi SP; Kim HJ; Kim TH; Lee OJ Korean J Gastroenterol; 2007 Nov; 50(5):306-12. PubMed ID: 18159162 [TBL] [Abstract][Full Text] [Related]
53. [Sports and the digestive tract]. Moser B Dtsch Med Wochenschr; 1990 Sep; 115(38):1448-51. PubMed ID: 2209425 [No Abstract] [Full Text] [Related]
54. [Obesity and Pancreatobiliary Disease]. Lee H; Koh DH Korean J Gastroenterol; 2020 May; 75(5):240-245. PubMed ID: 32448855 [TBL] [Abstract][Full Text] [Related]
55. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740 [TBL] [Abstract][Full Text] [Related]
56. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295 [TBL] [Abstract][Full Text] [Related]
57. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma. Snider EJ; Freedberg DE; Abrams JA Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172 [TBL] [Abstract][Full Text] [Related]
58. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features. Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092 [TBL] [Abstract][Full Text] [Related]
59. Barrett's esophagus in scleroderma: increased prevalence and radiographic findings. Recht MP; Levine MS; Katzka DA; Reynolds JC; Saul SH Gastrointest Radiol; 1988; 13(1):1-5. PubMed ID: 3350262 [TBL] [Abstract][Full Text] [Related]
60. Systemic Sclerosis: Gastrointestinal Disease and Its Management. Gyger G; Baron M Rheum Dis Clin North Am; 2015 Aug; 41(3):459-73. PubMed ID: 26210129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]